PTC
PGEN icon

Philadelphia Trust Company’s Precigen PGEN Stock Holding History

Philadelphia Trust Company’s Portfolio PGEN Stock Details PGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-96,145
Closed -$1.83M – 228
2017
Q3 		$1.83M Sell
96,145
-2,600
-3% -$53.5K 0.15% 96
2017
Q2 		$2.38M Sell
98,745
-250
-0.3% -$5.48K 0.2% 83
2017
Q1 		$1.96M Buy
98,995
+4,129
+4% +$92.2K 0.16% 96
2016
Q4 		$2.29M Sell
94,866
-25,165
-21% -$701K 0.18% 89
2016
Q3 		$3.33M Buy
120,031
+15,201
+15% +$402K 0.29% 69
2016
Q2 		$2.56M Buy
104,830
+17,077
+19% +$484K 0.22% 75
2016
Q1 		$2.95M Sell
87,753
-4,565
-5% -$144K 0.25% 65
2015
Q4 		$3.13M Buy
92,318
+23,030
+33% +$776K 0.26% 63
2015
Q3 		$2.18M Buy
69,288
+62,270
+887% +$3.04M 0.2% 76
2015
Q2 		$143K Sell
7,018
-87,738
-93% -$3.7M 0.53% 52
2015
Q1 		$4.11M Buy
94,756
+29,256
+45% +$1.05M 0.31% 65
2014
Q4 		$1.72M Buy
65,500
+3,871
+6% +$84.9K 0.14% 77
2014
Q3 		$1.09M Buy
61,629
+31,181
+102% +$637K 0.07% 101
2014
Q2 		$731K Buy
+30,448
New +$617K 0.05% 109

Other funds holding PGEN

TS
Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MVP
Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Philadelphia Trust Company's PGEN Position: Q4 2017 in Review

Philadelphia Trust Company sold out of Precigen (PGEN) in Q4 2017, closing a stake of 96,145 shares — an estimated $1.83M sold.

Philadelphia Trust Company first reported a position in PGEN in Q2 2014 and held it in 14 quarters. The position peaked at $4.11M in Q1 2015. 162 funds tracked by Wall St. Rank hold PGEN as of Q4 2017.

  • Philadelphia Trust Company reported no remaining Precigen position as of Q4 2017 after selling out during the quarter.
  • Philadelphia Trust Company sold 96,145 Precigen shares in Q4 2017, an estimated $1.83M.
  • Philadelphia Trust Company first reported a position in Precigen in Q2 2014 and held it in 14 quarters.
  • Philadelphia Trust Company's Precigen position peaked at $4.11M in Q1 2015.
  • 162 funds tracked by Wall St. Rank held Precigen as of Q4 2017.

Based on Philadelphia Trust Company's 13F filing for Q4 2017, filed 14 Feb 2018.